105 related articles for article (PubMed ID: 17379534)
1. Construction and delivery of gene therapy vector containing soluble TNFalpha receptor-IgGFc fusion gene for the treatment of allergic rhinitis.
He J; Wang T; Yao L; Chen A; Zhou B; Yu H; Jia R; Cheng C; Huan L; Zhang Z
Cytokine; 2006 Dec; 36(5-6):296-304. PubMed ID: 17379534
[TBL] [Abstract][Full Text] [Related]
2. Intranasal application of Epstein-Barr virus/lipoplex to abrogate eosinophillia in murine model of allergic rhinitis.
Han DM; Zhou B; Wang T; Wang XD; Fan EZ
Chin Med J (Engl); 2006 Jun; 119(12):991-7. PubMed ID: 16805982
[TBL] [Abstract][Full Text] [Related]
3. [Construction of adenoviral vector encoding soluble human sTNFRI-IgGFc cDNA and its expression in human airway smooth muscle cells (HASMCs)].
Su J; You C; Cai S; Ma L; Wang X; Wen Q; Luo W; Huang Y
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):774-9. PubMed ID: 18724696
[TBL] [Abstract][Full Text] [Related]
4. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
[TBL] [Abstract][Full Text] [Related]
5. [Construction of adenoviral vector encoding soluble human TNFRI-IgGFc cDNA and its expression in human bronchial epithelial cells].
Su J; You CX; Cai SX; Ma L; Wen Q; Luo W; Huang YT
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):517-21. PubMed ID: 18495580
[TBL] [Abstract][Full Text] [Related]
6. [Expression of sTNFR-IgGFc fusion gene in endothelial cell and its application in gene therapy for rheumatoid arthritis].
He J; Yao LH; Chen AJ; Yu H; Jia RQ; Cheng CS; Huan LF; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):378-83. PubMed ID: 16755914
[TBL] [Abstract][Full Text] [Related]
7. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis.
Kim JM; Lim BK; Ho SH; Yun SH; Shin JO; Park EM; Kim DK; Kim S; Jeon ES
Biochem Biophys Res Commun; 2006 Jun; 344(3):765-71. PubMed ID: 16631119
[TBL] [Abstract][Full Text] [Related]
8. [Cloning, expression and bio-activity assay of chimeric fusion protein sTNFRII-IgG Fc].
Xu CX; Yao LH; Zu D; Chen AJ; Huang GJ; Zhang ZQ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):178-81. PubMed ID: 12148279
[TBL] [Abstract][Full Text] [Related]
9. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
Glabinski AR; Bielecki B; Kawczak JA; Tuohy VK; Selmaj K; Ransohoff RM
Autoimmunity; 2004; 37(6-7):465-71. PubMed ID: 15621573
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
[TBL] [Abstract][Full Text] [Related]
11. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral delivery of recombinant soluble human tumor necrosis factor receptor 1 partially normalized mouse model of asthma.
Huang GH; Zeng XL; Cheng YX; Zhu SF; Luo W; Wen Q; Cai SX; Su J
J Investig Med; 2015 Jun; 63(5):765-72. PubMed ID: 25923882
[TBL] [Abstract][Full Text] [Related]
13. The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Jeon EJ; Lee SK; Park YS; Kim DH; Yum JH; Park CS
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):124-30. PubMed ID: 18585574
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model.
Mo JH; Kang EK; Quan SH; Rhee CS; Lee CH; Kim DY
Allergy; 2011 Feb; 66(2):279-86. PubMed ID: 21208219
[TBL] [Abstract][Full Text] [Related]
15. The effect of Bacillus Calmette-Guerin in a mouse model of allergic rhinitis.
Kim SW; Yeo SW
Otolaryngol Head Neck Surg; 2007 May; 136(5):720-5. PubMed ID: 17478204
[TBL] [Abstract][Full Text] [Related]
16. [Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].
An N; Xu C; Zhang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):116-7. PubMed ID: 11436637
[TBL] [Abstract][Full Text] [Related]
17. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
18. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
Guo Z; Wang S; Jiao Q; Xu M; Xu Z
Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
Sasaki Y; Hayashi T; Hasegawa K
Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen does not affect levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor types I and II in Gabonese children with uncomplicated Plasmodium falciparum malaria.
Matsiegui PB; Missinou MA; Issifou S; Necek M; Mavoungou E
Eur Cytokine Netw; 2007 Dec; 18(4):201-5. PubMed ID: 17964975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
